| abstract |
The invention relates to an octreotide acetate injection. The injection consists of 0.001-0.05% (w/v) octreotide acetate, an osmotic pressure regulator, a pH regulator and water for injection. The pH of the injection is 4.0-4.5. The osmotic pressure of the liquid is 285-320 mOsmol/kg. The invention scientifically screens the components and proportions used for preparing octreotide acetate injection, optimizes the preparation process and parameters, significantly improves the stability of octreotide acetate injection, and is compatible with any one of normal saline and 5% glucose or its combination Good compatibility, significantly reduce or even avoid the risk of microbial infection, significantly improve the quality of drugs, and ensure the safety and effectiveness of clinical drugs. |